Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Inventory
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Cash from Financing Activities (2022 - 2023)

Historic Cash from Financing Activities for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to $3.5 million.

  • Mainz Biomed's Cash from Financing Activities rose 326474.39% to $3.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $14.2 million, marking a year-over-year decrease of 4058.2%. This contributed to the annual value of $16.6 million for FY2024, which is 1667.95% up from last year.
  • Latest data reveals that Mainz Biomed reported Cash from Financing Activities of $3.5 million as of Q4 2023, which was up 326474.39% from $4.6 million recorded in Q3 2023.
  • In the past 5 years, Mainz Biomed's Cash from Financing Activities registered a high of $24.1 million during Q1 2022, and its lowest value of -$109513.0 during Q4 2022.